One more to sox list of upcomings: oral K. If this proves effective, it could change the outlook for a p53 activation. I do know there are other p53 activating drugs in the ongoing research, but an oral drug with the short half life of K would allow for maximum drug exposure with daily use. And no injection is a big plus. Krishna, keep testing.